Hemostemix ( (#TSXV: $HEM | #OTC: $HMTXF) Announces Dr. Mary Argent-Katwala as Clinical Trial Manager [  #investing #stocks #stockmarket #trading #investors #capitalmarkets #business #investments #news #healthcare  #stemcells #stemcelltherapy